SUNFISH Parts 1 and 2: 4-year Efficacy and Safety Data of Risdiplam in Types 2 and 3 Spinal Muscular Atrophy (SMA)

被引:1
|
作者
Servais, Laurent [1 ,2 ,3 ]
Oskoui, Maryam [4 ]
Day, John [5 ]
Deconinck, Nicholas [6 ,7 ]
Mazzone, Elena [8 ]
Nascimento, Andres [9 ]
Saito, Kyoko [10 ]
Vuillerot, Carole [11 ,12 ]
Baranello, Giovanni [13 ,14 ,15 ]
Boespflug-Tanguy, Odile [16 ]
Goemans, Nathalie [17 ]
Kirschner, Janbernd [18 ]
Kostera-Pruszczyk, Anna [19 ]
Braid, Jessica [20 ]
Papp, Gergely [21 ]
Gorni, Ksenija [22 ]
Martin, Carmen [20 ]
Scalco, Renata [23 ]
Yeung, Wai Yin [20 ]
Mercuri, Eugenio [21 ]
机构
[1] Hop Armand Trousseau, Mot Inst Myol AP HP, Paris, France
[2] Univ Oxford, Dept Paediat, MDUK Oxford Neuromuscular Ctr, Oxford, England
[3] Univ Liege, Univ Hosp Liege, Div Child Neurol, Ctr References Malad Neuromusculaires,Dept Pediat, Liege, Belgium
[4] McGill Univ, Dept Pediat & Neurol Neurosurg, Montreal, PQ, Canada
[5] Stanford Univ, Dept Neurol, Palo Alto, CA USA
[6] ULB, Childrens Univ Hosp, Ctr Reference Malad Neuromusculaires, Brussels, Belgium
[7] UZ Gent, Neuromuscular Ctr, Ghent, Belgium
[8] Fondazione Policlinico Gemelli IRCCS, Cathol Univ & Nemo Pediat, Pediat Neurol Inst, Rome, Italy
[9] Fdn Sant Joan Deu, Hosp Sant Joan Deu, Neuromuscular Unit,Neuropaediat Dept, CIBERER,ISCIII, Barcelona, Spain
[10] Tokyo Womens Med Univ, Inst Med Genet, Tokyo, Japan
[11] CHU Lyon, Dept Pediat Phys Med & Rehabil, Hop Mere Enfant, Lyon, France
[12] Univ Lyon, CNRS UMR 5310 INSERM U1217, Neuromyogen Inst, Lyon, France
[13] UCL, NIHR Great Ormond St Hosp, Dubowitz Neuromuscular Ctr, Biomed Res Ctr,Great Ormond St Inst Child Hlth, London, England
[14] Great Ormond St Hosp Trust, London, England
[15] Fondazione IRCCS Ist Neurol Carlo Besta, Dev Neurol Unit, Milan, Italy
[16] Hop Armand Trousseau, Mot Inst Myol AP HP, Paris, France
[17] Univ Paris Cite, UMR 1141, Neurodiderot, Paris, France
[18] Univ Hosp Leuven, Dept Paediat & Child Neurol, Neuromuscular Reference Ctr, Leuven, Belgium
[19] Univ Freiburg, Dept Neuropediat & Muscle Disorders, Med Ctr, Freiburg, Germany
[20] Med Univ Warsaw, Dept Neurol, Warsaw, Poland
[21] Roche Prod Ltd, Welwyn Garden City, Herts, England
[22] F Hoffmann La Roche Ltd, Pharma Dev, Safety, Basel, Switzerland
[23] F Hoffmann La Roche Ltd, PDMA Neurosci & Rare Dis, Basel, Switzerland
关键词
D O I
10.1212/WNL.0000000000203570
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
S34.009
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Sunfish parts 1 and 2: 4-year efficacy and safety data of risdiplam in types 2 and 3 spinal muscular atrophy (SMA)
    Oskoui, Maryam
    Deconinck, Nicolas
    Mazzone, Elena S.
    Nascimento, Andres
    Day, John W.
    Saito, Kayoko
    Vuillerot, Carole
    Baranello, Giovanni
    Boespflug-Tanguy, Odile
    Goemans, Nathalie
    Kirschnero, Janbernd
    Kostera-Pruszczyk, Anna
    Servais, Laurent
    Braid, Jessica
    Gerber, Marianne
    Gorni, Ksenija
    Martin, Carmen
    Yeung, Wai Yin
    Scalco, Renata S.
    Mercuri, Eugenio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [2] SUNFISH Parts 1 and 2: 4-year efficacy and safety data of risdiplam in Types 2 and 3 spinal muscular atrophy (SMA)
    Kostera-Pruszczyk, A.
    Day, J.
    Deconinck, N.
    Mazzone, E.
    Nascimento, A.
    Oskoui, M.
    Saito, K.
    Vuillerot, C.
    Baranello, G.
    Boespflug-Tanguy, O.
    Goemans, N.
    Kirschner, J.
    Servais, L.
    Braid, J.
    Gerber, M.
    Gorni, K.
    Martin, C.
    Yeung, W.
    Scalco, R.
    Mercuri, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 194 - 194
  • [3] SUNFISH parts 1 and 2: 3-year efficacy and safety of risdiplam in types 2 and 3 spinal muscular atrophy (SMA)
    Day, J.
    Deconinck, N.
    Mazzone, E.
    Nascimento, A.
    Oskoui, M.
    Saito, K.
    Vuillerot, C.
    Baranello, G.
    Boespflug-Tanguy, O.
    Goemans, N.
    Kirschner, J.
    Kostera-Pruszczyk, A.
    Servais, L.
    Braid, J.
    Gerber, M.
    Gorni, K.
    Martin, C.
    Scalco, R.
    Yeung, W.
    Mercuri, E.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S89 - S90
  • [4] FIREFISH Parts 1 and 2: 4-year efficacy and safety of risdiplam in Type 1 spinal muscular atrophy (SMA)
    Mazurkiewicz-Beldzinska, M.
    Baranello, G.
    Boespflug-Tanguy, O.
    Day, J.
    Deconinck, N.
    Klein, A.
    Masson, R.
    Mercuri, E.
    Rose, K.
    Servais, L.
    Vlodavets, D.
    Xiong, H.
    Zanoteli, E.
    El-Khairi, M.
    Gerber, M.
    Gorni, K.
    Kletzl, H.
    Palfreeman, L.
    Dodman, A.
    Darras, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 196 - 196
  • [5] SUNFISH: 3-year efficacy and safety of risdiplam in Types 2 and 3 spinal muscular atrophy
    Goemans, N.
    Day, J.
    Deconinck, N.
    Mazzone, E.
    Nascimento, A.
    Oskoui, M.
    Saito, K.
    Vuillerot, C.
    Baranello, G.
    Boespflug-Tanguy, O.
    Kirschner, J.
    Kostera-Pruszczyk, A.
    Servais, L.
    Braid, J.
    Gerber, M.
    Gorni, K.
    Martin, C.
    Scalco, R.
    Yeung, W.
    Mercuri, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 278 - 278
  • [6] SUNFISH: 3-year Efficacy and Safety of Risdiplam in Types 2 and 3 SMA
    Day, John W.
    Deconinck, Nicolas
    Kirschner, Janbernd
    Mazzone, Elena S.
    Nascimento, Andres
    Oskoui, Maryam
    Saito, Kyoko
    Vuillerot, Carole
    Baranello, Giovanni
    Boespflug-Tanguy, Odile
    Goemans, Nathalie
    Kostera-Pruszczyk, Anna
    Servais, Laurent
    Braid, Jessica
    Gerber, Marianne
    Gorni, Ksenija
    Martin, Carmen
    Scala, Renata S.
    Yeung, Wai Yin
    Mercuri, Eugenio
    NEUROLOGY, 2022, 98 (18)
  • [7] SUNFISH 3-YEAR EFFICACY AND SAFETY OF RISDIPLAM IN TYPES 2 AND 3 SMA
    Servais, Laurent
    Day, John W.
    Mazzone, Elena S.
    Oskoui, Maryam
    Baranello, Giovanni
    Gerber, Marianne
    Martin, Carmen
    McIver, Tammy
    Yeung, Wai Yin
    Mercuri, Eugenio
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [8] IREFISH Parts 1 and 2: 24-month safety and efficacy of risdiplam in type 1 spinal muscular atrophy (SMA)
    Masson, R.
    Boespflug-Tanguy, O.
    Darras, B.
    Day, J.
    Deconinck, N.
    Klein, A.
    Mazurkiewicz-Beldzinska, M.
    Mercuri, E.
    Rose, K.
    Servais, L.
    Vlodavets, D.
    Xiong, H.
    Zanoteli, E.
    Dodman, A.
    El-Khairi, M.
    Gaki, E.
    Gerber, M.
    Gorni, K.
    Kletzl, H.
    Baranello, G.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S134 - S134
  • [9] FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA)
    Darras, Basil
    Baranello, Giovanni
    Boespflug-Tanguy, Odile
    Day, John
    Deconinck, Nicholas
    Klein, Andrea
    Masson, Ricardo
    Mazurkiewicz-Beldzinska, Maria
    Mercuri, Eugenio
    Rose, Kristy
    Vlodavets, Dmitry
    Xiong, Hui
    Zanoteli, Edmar
    El-Khairi, Muna
    Gerber, Marianne
    Gorni, Ksenija
    Kletzl, Heidemarie
    Palfreeman, Laura
    Dodman, Angela
    Servais, Laurent
    NEUROLOGY, 2023, 100 (17)
  • [10] FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA)
    Servais, L.
    Baranello, G.
    Boespflug-Tanguy, O.
    Day, J.
    Deconinck, N.
    Klein, A.
    Masson, R.
    Mazurkiewicz-Beldzinska, M.
    Mercuri, E.
    Rose, K.
    Vlodavets, D.
    Xiong, H.
    Zanoteli, E.
    El-Khairi, M.
    Gerber, M.
    Gorni, K.
    Kletzl, H.
    Palfreeman, L.
    Dodman, A.
    Gaki, E.
    Darras, B.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S88 - S88